Show
10
20
30
40
results per page
COVID-19 Variant Supplement – Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID‑19 disease
Kaufmann, Daniel E |
Centre hospitalier de l'Université de Montréal | Operating Grant | $50,000
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
Leduc, Richard |
Université de Sherbrooke | Operating Grant | $50,000
CIHR Quebec 2021
Read More
A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination
De Serres, Sacha |
Université Laval | Operating Grant | $246,164
CIHR Quebec 2021
Read More
Prevention of the immunopathology induced by SARS-CoV-2
Estaquier, Jérôme |
Université Laval | Operating Grant | $499,800
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses
Liang, Chen |
Lady Davis Institute for Medical Research | Operating Grant | $50,000
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – Genre et intervention en dépendance en contexte de pandémie auprès de personnes en situation de précarité sociale
Bertrand, Karine |
Université de Sherbrooke | Operating Grant | $50,000
CIHR Quebec 2021
Read More
Developing a novel vaccine against COVID-19
Divangahi, Maziar |
McGill University | Project Grant | $569,925
CIHR Quebec 2021
Read More
Impact of Frailty and Sarcopenia on Post-COVID Recovery
Afilalo, Jonathan |
CIUSSS de Centre-Ouest-de-l'Ile-de-Montréal-Jewish General | Operating Grant | $470,179
CIHR Quebec 2021
Read More
COVID-19 Variant Supplement – Understanding the pathogenesis of COVID-19
Flamand, Louis |
CHU de Québec | Operating Grant | $50,000
CIHR Quebec 2021
Read More
Pathogenesis and immune escape potential of SARS-CoV-2 variants of concern.
Flamand, Louis |
CHU de Québec | Operating Grant | $252,900
CIHR Quebec 2021
Read More